Integrated Wealth Concepts’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,558	Closed	-$712K	–	1843
2024 Q4	$712K	Buy	16,558 +168	+1%	+$7.64K	0.01%	969
2024 Q3	$727K	Sell	16,390 -1,185	-7%	-$50.7K	0.01%	931
2024 Q2	$699K	Buy	17,575 +973	+6%	+$39.4K	0.01%	907
2024 Q1	$716K	Buy	16,602 +2,169	+15%	+$93.5K	0.01%	893
2023 Q4	$601K	Buy	14,433 +2,079	+17%	+$78.8K	0.01%	916
2023 Q3	$491K	Buy	12,354 +65	+0.5%	+$2.75K	0.01%	987
2023 Q2	$504K	Buy	12,289 +19	+0.2%	+$785	0.01%	979
2023 Q1	$503K	Hold	12,270	–	–	0.01%	854
2022 Q4	$502K	Sell	12,270 -168	-1%	-$6.99K	0.01%	658
2022 Q3	$500K	Buy	12,438 +279	+2%	+$11.9K	0.02%	593
2022 Q2	$511K	Buy	12,159 +1,303	+12%	+$54.6K	0.02%	597
2022 Q1	$491K	Buy	10,856 +2,618	+32%	+$115K	0.02%	578
2021 Q4	$380K	Buy	8,238 +1,354	+20%	+$64.2K	0.01%	685
2021 Q3	$327K	Buy	+6,884	New	+$342K	0.01%	708